TY - JOUR
T1 - Identifying amino acid residues that contribute to the cellular-DNA binding site on retroviral integrase
AU - Nowak, Matthew G.
AU - Sudol, Malgorzata
AU - Lee, Noelle E.
AU - Konsavage, Wesley M.
AU - Katzman, Michael
N1 - Funding Information:
This work was supported by research grants from the W. W. Smith Charitable Trust and the Pennsylvania Department of Health Tobacco Settlement Funds; the Department specifically disclaims responsibility for any analyses, interpretations, or conclusions. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081).
PY - 2009
Y1 - 2009
N2 - Although retroviral integrase specifically trims the ends of viral DNA and inserts these ends into any sequence in cellular DNA, little information is available to explain how integrase distinguishes between its two DNA substrates. We recently described novel integrase mutants that were improved for specific nicking of viral DNA but impaired at joining these ends into nonviral DNA. An acidic or bulky substitution at one particular residue was critical for this activity profile, and the prototypic protein - Rous sarcoma virus integrase with an S124D substitution - was defective at nonspecifically binding DNA. We have now characterized 19 (including 16 new) mutants that contain one or more aspartic acid substitutions at residues that extend over the surface of the protein and might participate with residue 124 in binding cellular DNA. In particular, every mutant with an aspartate substitution at residue 98 or 128, similar to the original S124D protein, showed improved specific nicking of viral DNA but disturbed nonspecific nicking of nonviral DNA. These data describe a probable cellular-DNA binding platform that involves at least 5 amino acids, in the following order of importance: 124 > 128 > (98, 125) > 123. These experimental data are vital for new models of integrase and will contribute to identifying targets for the next generation of integrase inhibitors.
AB - Although retroviral integrase specifically trims the ends of viral DNA and inserts these ends into any sequence in cellular DNA, little information is available to explain how integrase distinguishes between its two DNA substrates. We recently described novel integrase mutants that were improved for specific nicking of viral DNA but impaired at joining these ends into nonviral DNA. An acidic or bulky substitution at one particular residue was critical for this activity profile, and the prototypic protein - Rous sarcoma virus integrase with an S124D substitution - was defective at nonspecifically binding DNA. We have now characterized 19 (including 16 new) mutants that contain one or more aspartic acid substitutions at residues that extend over the surface of the protein and might participate with residue 124 in binding cellular DNA. In particular, every mutant with an aspartate substitution at residue 98 or 128, similar to the original S124D protein, showed improved specific nicking of viral DNA but disturbed nonspecific nicking of nonviral DNA. These data describe a probable cellular-DNA binding platform that involves at least 5 amino acids, in the following order of importance: 124 > 128 > (98, 125) > 123. These experimental data are vital for new models of integrase and will contribute to identifying targets for the next generation of integrase inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=67349135952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67349135952&partnerID=8YFLogxK
U2 - 10.1016/j.virol.2009.04.014
DO - 10.1016/j.virol.2009.04.014
M3 - Article
C2 - 19447461
AN - SCOPUS:67349135952
SN - 0042-6822
VL - 389
SP - 141
EP - 148
JO - Virology
JF - Virology
IS - 1-2
ER -